Transforming the Way the World Sees the Genome

Dr. Albert Luderer has served the Bionano Board of Directors since November 2011 and served as Chairman of the Board of Directors since June 2024. He is currently also serving as interim President and CEO.

Albert Luderer has three decades of experience in biotechnology, with special focuses on technology, business development and commercialization.

Dr. Luderer is CEO and board director at personalized diagnostics company Integrated Diagnostics. He also serves as CEO and board director of molecular therapeutics and imaging company Indi Molecular.

Dr. Luderer previously served as president and CEO of BioTrove, a venture-backed molecular biological tools company that was acquired by Life Technologies. Additionally, Dr. Luderer was CEO of venture-backed therapeutics company Light Sciences and president and COO of bioMérieux, Inc.

Senior management positions at Dianon Systems (LabCorp), Boehringer Mannheim (Roche), and Corning round out Dr. Luderer’s experience in the industry. He earned his PhD from Rutgers University, where he was a National Science Foundation predoctoral fellow, and performed postgraduate work in immunology at Jefferson Medical College.

Mark Oldakowski has a 20-year history of success in the development of systems for the life sciences and medical device industries.

Prior to joining Bionano Genomics, Mark led a global team at Brooks Life Science Systems in the development of sample analyzers, high-throughput screening solutions, and chemical storage and biobank systems. Prior to his time at Brooks, Mark was with Affymetrix, where he launched the array platform that is widely used today for GWAS and other genomics applications. Mark also spent time at Siemens Healthcare Diagnostics on the development of equipment for diagnostic core labs. During his 13 years at Life Technologies (formerly Applied Biosystems) he held various levels of responsibility in the development of systems for real-time PCR, sequencing and sample preparation. Mark holds a bachelor’s degree in electrical engineering and a master’s degree in computer and systems engineering from Rensselaer Polytechnic Institute in New York.

Alex Hastie, PhD, is Bionano’s Chief Scientific Officer where he leads global scientific strategy, innovation, and research initiatives to advance genome analysis solutions for translational and clinical applications. Dr. Hastie and his teams are important drivers for the continued development and adoption of optical genome mapping (OGM).

Dr. Hastie is one of the foundational architects of Bionano’s core platform and spent 14 years advancing OGM technology across cytogenomics, oncology, and rare disease research. He has also led medical affairs and strategic alliances in oncology genomic testing, including key executive roles at Arima Genomics and Inocras. Dr. Hastie has more than 70 peer reviewed publications and eight patents and patent applications.

Dr. Hastie holds a PhD in Molecular and Cellular Biophysics and Biochemistry from Roswell Park Cancer Institute and completed a postdoctoral research fellowship at the Max Planck Institute of Biochemistry.

Donna Polizio has over 30 years of experience working in diagnostic and life sciences companies including Hologic, Redpath, Aureon and Genomic Health, where she held leadership roles in areas including research and development, applications, sales and market access, with a special emphasis in In-Vitro Diagnostics (IVD) and Laboratory Developed Tests (LDTs).

She joined Bionano from Exact Sciences, where she most recently held the role of Vice President, U.S. Managed Care and Reimbursement. Donna has obtained coverage and reimbursement for some of the most valued diagnostics of the last several decades. She received a bachelor’s degree in biology from Queens College and a master’s degree in organizational leadership from Mercy College.

Jonathan Dixon is an experienced legal advisor with over two decades of experience counseling leading life science and medical device companies in intellectual property, technology transactions, and M&A.

Prior to joining Bionano Genomics, Jonathan held a variety of legal positions, including associate general counsel, intellectual property at Becton, Dickinson and Company (“BD”) and CareFusion, and assistant general counsel and director of legal at BD and GeneOhm Sciences.  Jonathan holds bachelor’s degrees in microbiology and economics from Brigham Young University, and a juris doctor degree from Lewis & Clark Law School.

Mark Adamchak serves as Bionano’s Chief Accounting Officer. He joined the company as Controller in June 2018 and led the accounting organization through Bionano’s initial public offering. Since joining Bionano, he has taken on increasingly senior leadership roles, with responsibilities spanning accounting, financial reporting, treasury, investor relations, capital markets, and Sarbanes-Oxley compliance.

Before joining Bionano, Mark held accounting and finance leadership positions at Pathway Genomics, Intuit, and SAIC. At Pathway Genomics, his responsibilities included accounting for insurance reimbursements within a private life sciences company. At Intuit, he supported merger and acquisition integration activities and addressed software revenue recognition matters. During his tenure at SAIC, he supported M&A teams with financial due diligence, led accounting process and integration initiatives, and gained SEC reporting experience at a large accelerated filer. He began his career in public accounting with KPMG.

Mark is a licensed CPA and earned a Bachelor of Business Administration in Accounting from James Madison University.

Cory Kreeck is a people leader and human resources executive with 25 years of experience leading global teams across business functions. He brings a people-focused and entrepreneurial approach to human resources.

Prior to Bionano, Cory led human resources efforts at SpinLaunch, where he was Head of People, and Beachbody, where he held a number of roles with increasing responsibility, including Group Vice President, People Operations. Cory received a Bachelor of Science in philosophy from Utah State University and a master’s degree in organizational leadership from Biola University. Cory is also a Professional Certified Coach with the International Coaching Federation.